| Cancer Type | Outstanding Efficacy |
|---|---|
| Malignant Brain Tumors (Glioblastoma) | Significantly extends survival compared to traditional radiation therapy |
| Recurrent Head and Neck Cancer | Kills drug-resistant cells without the need for reoperation |
| Deep Metastatic Cutaneous Melanoma | Relieves pain, improves symptoms, and controls metastasis |
| Thyroid Cancer, Lung Cancer, Liver Cancer | Clinical research is continuously expanding |
| Tumors Resistant to Chemotherapy/ Radiation |
Remains effective when other methods fail |

Inject a drug containing Boron-10 into the body, allowing it to selectively accumulate in cancer cells

Irradiate the tumor area with a low-energy neutron beam to trigger a reaction between Boron-10 and neutrons, producing high-energy alpha particles and lithium ions

These particles release energy inside cancer cells, precisely destroying cell DNA without affecting surrounding normal tissues.
Thus, energy release is completely confined within cancer cells a level of precision that traditional radiationtherapy cannot achieve.
These centers are open to both domestic and international patients, providing one-stop services such as translation, medical record management, and full-process treatment coordination
| Comparison Item | BNCT | Traditional Radiation Therapy / Chemotherapy |
|---|---|---|
| Mechanism of Action | Selectively kills cancer cells via boron-neutron reaction | Wide-range irradiation, affecting the whole body |
| Treatment Scope | Precise to individual cells, protecting normal tissues | Large irradiation range, prone to tissue damage |
| Side Effects | Mild and temporary | Hair loss, mucositis, fatigue, leukopenia |
| Number of Treatments | Only 1–2 sessions needed | 15–30 sessions, multiple treatment cycles |
| Quality of Life | Maintained well, fast recovery | Significant impact, reduced quality of life |


